Seventeen And Counting – Bumper Crop Of New EU Filings
Executive Summary
Orphan drugs and COVID-19 products are among the latest filings under review by the European Medicines Agency for potential pan-EU approval.
You may also be interested in...
New EU Filings
Tabelecleucel, Atara Biotherapeutics’ advanced therapy for the treatment of Epstein-Barr virus-positive post-transplant lymphoproliferative disease, is among the latest new medicines that have been submitted for review for potential pan-EU approval.
EU Accelerated Assessment Tracker
The Pink Sheet's EU accelerated assessment tracker has been updated to include developments relating to investigational products from Roche and CSL Behring/UniQure.
Accelerated Assessment Success In EU For CSL Behring And Roche
There have been some recent successes on the accelerated assessment front in the EU but more requests are rejected than granted.